Skip to content
Screener

Solventum SOLV Total Revenue

Total Revenue at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$4.98B-9.5%
3M logo
3MMMM
$6.5B+2.5%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$27.8M+18.6%
Cardinal Health logo
Cardinal HealthCAH
$60.94B+11.0%
UnitedHealth Group logo
UnitedHealth GroupUNH
$111.72B+2.0%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
$898M-4.1%

Segments

By segment

See full
MedSurg$1.37B+12.6%
Dental Solutions$396M+17.2%
Health Information Systems$354M+4.4%
Purification and Filtration Segment$0-100%

By geography

See full
United States$4.56B+2.0%

By product

See full
Cost of software and rentals$511M+3.7%

Other financials

Income statement

See full
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Net sales of product$1,698$1,668$3,211$3,265
Net sales of software and rentals5114931,005966
Total net sales2,2092,1614,2164,231
Cost of product8078651,6031,700
Cost of software and rentals116121231242
Gross profit1,2861,1752,3822,289
Selling, general and administrative expenses9277721,7541,541
Research and development expenses178189367381

Item 1. Financial Statements

FAQ

What is Solventum's total revenue?
Solventum (SOLV) reported total revenue of $2.21B in Q2 2026.
How has Solventum's total revenue changed year-over-year?
Solventum's total revenue increased by 2.2% year-over-year, from $2.16B to $2.21B.
What is the long-term trend for Solventum's total revenue?
Over 3 years (2022 to 2025), Solventum's total revenue has grown at a 0.8% compound annual growth rate (CAGR), from $8.13B to $8.33B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Solventum's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude